About 50 results
Open links in new tab
  1. January 14 2026 - JPM26: AstraZeneca's $80B revenue target 'very …

    5 days ago · Confidence is on full display at JPM, as companies talk up revenue targets, pipeline momentum, and dealmaking strength—tempered by ongoing regulatory and pricing realities.JPM26: …

  2. AstraZeneca | Cafepharma

    5 days ago · AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the drugmaker's $50 billion investment plan in the company's largest …

  3. AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device …

    Aug 1, 2022 · Anonymous board for AstraZeneca. We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in bits and pieces. …

  4. Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales

    Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales

  5. July 24 2025 - AstraZeneca drug acquired in Alexion deal succeeds in ...

    Jul 24, 2025 · AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trialAstraZeneca boardPharma giant Roche sees income soar in first halfRoche boardNovartis to pay …

  6. Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma

    3 days ago · Friday’s CP Today spans JPM takeaways, market moves, M&A chatter, and lingering regulatory questions as the week comes to a close. Novo shares jump on ‘encouraging’ Wegovy pill …

  7. Cafepharma News

    Latest news and updates on pharmaceutical and medical sales, including breakthrough treatments and industry trends.

  8. AstraZeneca’s Fasenra meets primary endpoint in Phase III rare ...

    Sep 12, 2023 · The Phase III trial compared the efficacy of Fasenra with the standard treatment of GSK’s Nucala in patients with eosinophilic granulomatosis with polyangiitis.

  9. Pfizer | Cafepharma Message Boards | Pharma Sales, Device Sales, Lab …

    Feb 23, 2025 · Anonymous board for Pfizer. We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in bits and pieces. We’re …

  10. AstraZeneca Deepens Cancer Cell Therapy Portfolio with Neogene …

    AstraZeneca and Neogene Therapeutics have entered into a definitive acquisition agreement in which AstraZeneca will buy all outstanding equity in the smaller company. The deal aims to advance T-cell …